FREE Account Opening + No Clearing Fees
Loading...

Rolex Rings IPO vs Tatva Chintan Pharma IPO

Comparision between Rolex Rings IPO and Tatva Chintan Pharma IPO.

IPO Details

Rolex Rings IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Rolex Rings IPO Tatva Chintan Pharma IPO
Logo Rolex Rings IPO Logo Tatva Chintan Pharma IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE, NSE BSE, NSE
Lead Managers Equirus Capital Private Limited

Idbi Capital Market Services Limited

Jm Financial Limited
ICICI Securities Limited

Jm Financial Limited
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Rolex Rings IPO is up to ₹731.00 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of Rolex Rings IPO is ₹900.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.

  Rolex Rings IPO Tatva Chintan Pharma IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹880.00 per share ₹1,073.00 per share
Issue Price (Upper) ₹900.00 per share ₹1,083.00 per share
Issue Price (Final) ₹900.00 per share ₹1,083.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 16 shares 13 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹56.00 Cr up to ₹225.00 Cr
OFS Issue Size 75,00,000 shares
OFS Issue Size (Amount) up to ₹675.00 Cr up to ₹275.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹731.00 Cr up to ₹500.00 Cr

IPO Timetable

Rolex Rings IPO opens on Jul 28, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of Rolex Rings IPO and Tatva Chintan Pharma IPO is Jul 30, 2021, and Jul 20, 2021, respectively.

  Rolex Rings IPO Tatva Chintan Pharma IPO
Anchor Bid Date
Issue Open Jul 28, 2021 Jul 16, 2021
Issue Close Jul 30, 2021 Jul 20, 2021
Basis Of Allotment (Tentative) Aug 04, 2021 Jul 26, 2021
Initiation of Refunds (Tentative) Aug 05, 2021 Jul 27, 2021
Credit of Share (Tentative) Aug 06, 2021 Jul 28, 2021
Listing date (Tentative) Aug 09, 2021 Jul 29, 2021
Anchor Lockin End date 1 Sep 03, 2021 Aug 25, 2021
Anchor Lockin End date 2 Nov 02, 2021 Oct 24, 2021

Financials

Rolex Rings IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .

  Rolex Rings IPO Tatva Chintan Pharma IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 7,969.24 6,861.73 7,822.57
Total Revenue 6,197.57 6,753.32 9,112.54
Profit After Tax 869.55 529.41 590.41
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 3,148.03 2,489.38 1,875.08
Total Revenue 3,062.92 2,646.22 2,068.01
Profit After Tax 522.62 377.89 205.43
Promoter Shareholding (Pre-Issue) 58.99% 100%
Promoter Shareholding (Post-Issue) 57.64% 79.17%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Rolex Rings IPO retail investors (RII) are offered 28,42,778 shares while in Tatva Chintan Pharma IPO retail investors are offered 28,42,778 shares. Qualified institutional buyers (QIB) are offered 16,24,444 shares in Rolex Rings IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.

  Rolex Rings IPO Tatva Chintan Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 16,24,444 shares 9,31,966 shares
NII 12,18,334 shares 6,98,975 shares
RII 28,42,778 shares 16,30,941 shares
Employee 0 shares 0 shares
Others
Total 56,85,556 shares 32,61,882 shares

Bids Received (Subscription)

Rolex Rings IPO subscribed 130.44x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.

  Rolex Rings IPO Tatva Chintan Pharma IPO
QIB (times) 143.58x 185.23x
NII (times) 360.11x 512.22x
Big NII (times)
Small NII (times)
RII (times) 24.49x 35.35x
Employee (times)
Other (times)
Total (times) 130.44x 180.36x

Comments

Add a public comment...